Proof-of-concept trial in a single patient shows that cells can survive transplantation without immunosuppression ...

Researchers are developing a two-part therapy for type 1 diabetes: lab-made insulin-producing cells paired with ...

Add Yahoo as a preferred source to see more of our stories on Google. This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with ...

Our body controls the levels of sugar in our blood with a hormone called insulin, which is made by beta cells in the pancreas. In type 1 diabetes, the immune system erroneously attacks those beta ...

A new gene therapy approach aimed at protecting people with type 1 diabetes from developing diabetic kidney disease—a serious and common complication of the condition, has shown promising results in a ...

Obviously caveats must be drawn from a mouse model such as this, but the results have supercharged the team's determination.

Scientists at the University of Wisconsin–Madison have uncovered a possible way to protect key cells in the pancreas that are targeted during the development of Type 1 diabetes. Subscribe to our ...

This article is part of “Innovations In: Type 1 Diabetes,” an editorially independent special report that was produced with financial support from Vertex. In 2024 Stephen Rich and his colleagues ...

At the Medical University of South Carolina (MUSC), researcher Leonardo Ferreira, Ph.D., is leading an ambitious effort to change how type 1 diabetes ...

Researchers identify genetic markers that predict the rate of β-cell failure in type 1 diabetes, facilitating earlier, personalized care strategies Type 1 diabetes (T1D) is an autoimmune condition ...

A test using genetics to predict who is at the highest risk of developing type 1 diabetes could one day be applied to largescale health studies, to identify adults who could benefit from new drugs, ...